Aprogen Pharmaceuticals Inc (003060) — Cash Flow Quality Index
Aprogen Pharmaceuticals Inc (003060) has a Cash Flow Quality Index of -13.36x as of March 2023. Operating cash flow of ₩-14.74 Billion is below net income of ₩1.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Aprogen Pharmaceuticals Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aprogen Pharmaceuticals Inc Cash Flow Quality Index (2015–2022)
Historical Cash Flow Quality Index for Aprogen Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 003060 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Aprogen Pharmaceuticals Inc (2015–2022)
Year-by-year earnings quality comparison for Aprogen Pharmaceuticals Inc. For live market cap and the full company financial profile, see Aprogen Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.28x | ₩25.73 Billion | ₩7.84 Billion | ▲ +527.2% |
| 2021 | -0.77x | ₩-6.23 Billion | ₩8.10 Billion | ▼ -206.9% |
| 2020 | 0.72x | ₩8.09 Billion | ₩11.25 Billion | ▲ +7.4% |
| 2015 | 0.67x | ₩1.85 Billion | ₩2.76 Billion | — |